United States - Re-Export of Insulin in Dosage Forms

Since 2014, United States Re-Export of Insulin in Dosage Forms jumped by 47.1% year on year. At $6,604,316 in 2019, the country was number 2 comparing other countries in Re-Export of Insulin in Dosage Forms. United Arab Emirates topped the ranking with $37,345,759.11 in 2019, -4.3% compared to 2018. United Arab Emirates witnessed the best average annual growth at +119.7% per year, while Canada witnessed the worst performance at -13.3% per year.

US Dollars0M2M4M6M8M1991199520002005201020152019© NationMasterSource:United Nations Statistical OfficeUnited States - Re-Export of Insulin in Dosage Forms

Date US Dollars
2019 6,604,316.00
2018 7,175,687.00
2017 4,719,680.00
2016 2,053,396.00
2015 782,658.00
Download all data from 1991 to 2019

How does United States rank in Re-Export of Insulin in Dosage Forms?

# 10 Countries US Dollars Last YoY 5‑years CAGR
1 #1
United Arab Emirates
37,345,759.11 2019 -4.3 % +119.7 % View data
2 #2
United States
6,604,316.00 2019 -8.0 % +47.1 % View data
3 #3
Jordan
4,672,370.00 2018 +45.3 % NA View data
4 #4
Saudi Arabia
3,443,080.50 2016 NA NA View data
5 #5
Barbados
2,381,725.20 2019 +2.5 % -1.6 % View data
Compare all 10 countries

Go Top